NBC Securities’s Acurx Pharmaceuticals ACXP Stock Holding History

NBC Securities’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33K	Hold	1,500	–	–	﹤0.01%	2218
2026 Q1	$5.57K	Hold	1,500	–	–	﹤0.01%	2088
2025 Q4	$3.73K	Hold	1,500	–	–	﹤0.01%	2276
2025 Q3	$6.43K	Hold	1,500	–	–	﹤0.01%	2129
2025 Q2	$15K	Hold	1,500	–	–	﹤0.01%	1813
2025 Q1	$11K	Buy	1,500 +1,499	+149,900%	+$20.2K	﹤0.01%	1692
2024 Q4	$15	Sell	1 -949	-100%	-$28.6K	﹤0.01%	1168
2024 Q3	$36K	Hold	950	–	–	﹤0.01%	1276
2024 Q2	$42K	Buy	950 +250	+36%	+$11K	﹤0.01%	1188
2024 Q1	$34K	Buy	+700	New	+$45.5K	﹤0.01%	1244

Other funds holding ACXP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PFS

Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

NBC Securities's ACXP Position: Q2 2026 in Review

NBC Securities held its Acurx Pharmaceuticals (ACXP) position steady in Q2 2026 at 1,500 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

NBC Securities first reported a position in ACXP in Q1 2024 and has held it in 10 quarters since. The position peaked at $42K in Q2 2024. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

NBC Securities held 1,500 shares of Acurx Pharmaceuticals worth $2.33K as of Q2 2026.
NBC Securities left its Acurx Pharmaceuticals share count unchanged in Q2 2026.
Acurx Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2218 holding.
NBC Securities first reported a position in Acurx Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
NBC Securities's Acurx Pharmaceuticals position peaked at $42K in Q2 2024.
19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.